| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/27/2023 | 669.23% | Noble Capital Markets | → $10 | Initiates Coverage On | → Outperform |
| 08/22/2023 | 592.31% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight |
| 05/26/2023 | 1823.08% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
| 06/01/2022 | 1900% | SVB Leerink | $33 → $26 | Maintains | Outperform |
| 11/24/2021 | 1823.08% | HC Wainwright & Co. | $35 → $25 | Maintains | Buy |
| 04/27/2021 | 2438.46% | SVB Leerink | $34 → $33 | Maintains | Outperform |
| 03/23/2021 | 1823.08% | Cantor Fitzgerald | → $25 | Initiates Coverage On | → Overweight |
| 02/08/2021 | 2515.38% | SVB Leerink | → $34 | Initiates Coverage On | → Outperform |
What is the target price for Eledon Pharma (ELDN)?
The latest price target for Eledon Pharma (NASDAQ: ELDN) was reported by Noble Capital Markets on September 27, 2023. The analyst firm set a price target for $10.00 expecting ELDN to rise to within 12 months (a possible 669.23% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eledon Pharma (ELDN)?
The latest analyst rating for Eledon Pharma (NASDAQ: ELDN) was provided by Noble Capital Markets, and Eledon Pharma initiated their outperform rating.
When is the next analyst rating going to be posted or updated for Eledon Pharma (ELDN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eledon Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eledon Pharma was filed on September 27, 2023 so you should expect the next rating to be made available sometime around September 27, 2024.
Is the Analyst Rating Eledon Pharma (ELDN) correct?
While ratings are subjective and will change, the latest Eledon Pharma (ELDN) rating was a initiated with a price target of $0.00 to $10.00. The current price Eledon Pharma (ELDN) is trading at is $1.30, which is within the analyst's predicted range.